Holen Sie sich die Stockscreener-App
37.39
1.77%
0.65
Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten
Rigel Pharmaceuticals Inc (RIGL) Balance Sheet - TradingKey
Rigel Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:RIGL - TradingView
Rigel Pharmaceuticals Inc (RIGL) Cash Flow - TradingKey
Rigel Pharmaceuticals Inc (RIGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rigel Pharmaceuticals Inc (RIGL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
RIGL|Rigel Pharmaceuticals Inc|Price:36.740|Chg%:-0.080 - TradingKey
TradingKey - TradingKey
Rigel Pharmaceuticals, Inc. Revenue Breakdown – MUN:RI2 - TradingView
Rigel Pharmaceuticals (RIGL) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Up and down the ladder: The latest comings and goings - STAT
Rigel Pharmaceuticals Inc (RIGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RIGEL PHARMACEUTICALS INC (RIGL) Stock Chart - ChartMill
(RIGL) Risk Channels and Responsive Allocation - Stock Traders Daily
RIGL Stock Jumps 15%, Short Interest Surges To Record High – Why Is Retail Eyeing A Further 40% Upside? - Stocktwits
Rigel Pharmaceuticals Inc (RIGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rigel Pharmaceuticals (RIGL) Slips 2.94% as Selling Pressure Tests Key Support LevelsTrend Reversal Picks - dars.gov.et
Rigel Pharmaceuticals Holds Steady Near Resistance as Biotech Sector WatchesImpulse Wave - dars.gov.et
Form 4 Rigel Pharmaceuticals Inc For: 10 July By Investing.com - Investing.com Australia
Rigel Pharmaceuticals (RIGL) CMO receives 24,400-share RSU equity award with 4-year vesting - Stock Titan
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - AOL.com
Rigel Pharmaceuticals (RIGL) Investor update Summary - Quartr
Rigel Pharmaceuticals (RIGL) Q1 2026 earnings summary - Quartr
Rigel Pharmaceuticals (RIGL) Corporate presentation Summary - Quartr
Rigel Pharmaceuticals (RIGL) Proxy filing Summary - Quartr
Rigel Pharmaceuticals (RIGL) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Rigel Pharmaceuticals, Inc. Announces Inducem - Moomoo
Rigel Pharmaceuticals, Inc. (RIGL) Latest Stock News & Headlines - Yahoo Finance
Rigel awards new hires 13,375 RSUs under its inducement plan - Stock Titan
RI2 Forecast — Price Target — Prediction for 2027 - TradingView
Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer - Sahm
Rigel appoints Alison L Hannah as chief medical officer - MSN
Rigel Pharmaceuticals, Inc. Files 8-K With SEC: Corporate Details, Stock Info, and Compliance Updates - Minichart
Alison Hannah joins Rigel (NASDAQ: RIGL) as new EVP and Chief Medical Officer - Stock Titan
Rigel Pharmaceuticals Appoints Dr. Alison L. Hannah as CMO (RIGL) - GuruFocus
Rigel Pharmaceuticals Appoints Alison L. Hannah as Chief Medical Officer - citybiz
Press Release: Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer - Moomoo
Rigel Pharmaceuticals appoints Dr. Alison Hanna... - Pluang
(RIGL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
RIGL Q1 2026 Earnings: EPS Misses Estimates, Revenue Not Disclosed, Stock Edges HigherRetail Earnings Report - dars.gov.et
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) added to Russell Microcap Value Benchmark Index - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS: RIGL) added to Russell 2000 Value Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – BX:RIGL - TradingView
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
RIGL Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Price to sales forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Enterprise value to revenue forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
Price to earnings forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Price to earnings forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
A40EFY Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
Price to book forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Enterprise value to EBITDA forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Rigel Pharmaceuticals Inc (RIGL) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Rigel Pharmaceuticals, Inc. Actuals & Estimates (DUS:RI2) - TradingView
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):